Follow
Pamela Pollock
Title
Cited by
Cited by
Year
Integrated genomic characterization of endometrial carcinoma
DA Levine, ...
Nature 497 (7447), 67-73, 2013
47372013
Molecular classification of cutaneous malignant melanoma by gene expression profiling
M Bittner, P Meltzer, Y Chen, Y Jiang, E Seftor, M Hendrix, M Radmacher, ...
Nature 406 (6795), 536-540, 2000
25722000
High frequency of BRAF mutations in nevi
PM Pollock, UL Harper, KS Hansen, LM Yudt, M Stark, CM Robbins, ...
Nature genetics 33 (1), 19-20, 2003
20262003
Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: impact on prognosis and benefit from adjuvant therapy
A León-Castillo, SM De Boer, ME Powell, LR Mileshkin, HJ Mackay, ...
Journal of Clinical Oncology 38 (29), 3388, 2020
4752020
Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative
E Stelloo, T Bosse, RA Nout, HJ MacKay, DN Church, HW Nijman, ...
Modern pathology 28 (6), 836-844, 2015
4202015
Proteasome inhibitors trigger NOXA-mediated apoptosis in melanoma and myeloma cells
JZ Qin, J Ziffra, L Stennett, B Bodner, BK Bonish, V Chaturvedi, F Bennett, ...
Cancer research 65 (14), 6282-6293, 2005
4002005
Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes
PM Pollock, MG Gartside, LC Dejeza, MA Powell, MA Mallon, H Davies, ...
Oncogene 26 (50), 7158-7162, 2007
3702007
Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia
PM Pollock, K Cohen-Solal, R Sood, J Namkoong, JJ Martino, A Koganti, ...
Nature genetics 34 (1), 108-112, 2003
3242003
The CDKN2A (p16) Gene and Human Cancer
WD Foulkes, TY Flanders, PM Pollock, NK Hayward
Molecular medicine 3, 5-20, 1997
3121997
Brivanib alaninate, a dual inhibitor of vascular endothelial growth factor receptor and fibroblast growth factor receptor tyrosine kinases, induces growth inhibition in mouse …
H Huynh, VC Ngo, J Fargnoli, M Ayers, KC Soo, HN Koong, CH Thng, ...
Clinical Cancer Research 14 (19), 6146-6153, 2008
2602008
Compilation of somatic mutations of the CDKN2 gene in human cancers: Non‐random distribution of base substitutions
PM Pollock, JV Pearson, NK Hayward
Genes, Chromosomes and Cancer 15 (2), 77-88, 1996
2181996
FGFR2 point mutations in 466 endometrioid endometrial tumors: relationship with MSI, KRAS, PIK3CA, CTNNB1 mutations and clinicopathological features
SA Byron, M Gartside, MA Powell, CL Wellens, F Gao, DG Mutch, ...
PloS one 7 (2), e30801, 2012
2092012
Microarray expression profiling in melanoma reveals a BRAF mutation signature
S Pavey, P Johansson, L Packer, J Taylor, M Stark, PM Pollock, ...
Oncogene 23 (23), 4060-4067, 2004
2092004
Cloning and characterization of a novel human gene related to vascular endothelial growth factor.
S Grimmond, J Lagercrantz, C Drinkwater, G Silins, S Townson, P Pollock, ...
Genome Research 6 (2), 124-131, 1996
2031996
A genome-based strategy uncovers frequent BRAF mutations in melanoma
PM Pollock, PS Meltzer
Cancer cell 2 (1), 5-7, 2002
2012002
CDKN2A/p16 Is Inactivated in Most Melanoma Cell Lines
M Castellano, PM Pollock, MK Walters, LE Sparrow, LM Down, ...
Cancer research 57 (21), 4868-4875, 1997
1801997
p53-independent NOXA induction overcomes apoptotic resistance of malignant melanomas
JZ Qin, L Stennett, P Bacon, B Bodner, MJC Hendrix, REB Seftor, ...
Molecular cancer therapeutics 3 (8), 895-902, 2004
1782004
Inhibition of activated fibroblast growth factor receptor 2 in endometrial cancer cells induces cell death despite PTEN abrogation
SA Byron, MG Gartside, CL Wellens, MA Mallon, JB Keenan, MA Powell, ...
Cancer research 68 (17), 6902-6907, 2008
1762008
Targeting mutant fibroblast growth factor receptors in cancer
H Greulich, PM Pollock
Trends in molecular medicine 17 (5), 283-292, 2011
1712011
Loss-of-function fibroblast growth factor receptor-2 mutations in melanoma
MG Gartside, H Chen, OA Ibrahimi, SA Byron, AV Curtis, CL Wellens, ...
Molecular Cancer Research 7 (1), 41-54, 2009
1562009
The system can't perform the operation now. Try again later.
Articles 1–20